Huntsman Corporation 10-Q Summary: Period Ended September 30, 2025
Business Context and Reporting Period
This Quarterly Report on Form 10-Q covers the period ended September 30, 2025, for Huntsman Corporation and its wholly-owned subsidiary, Huntsman International LLC. Huntsman is a global manufacturer of diversified organic chemical products operating in three segments: Polyurethanes, Performance Products, and Advanced Materials. The company reported a net loss for the quarter and the year-to-date period, driven by lower selling prices, restructuring costs, and specific non-recurring items.
Key Financial Metrics (Nine Months Ended Sept 30, 2025)
| Metric | 2025 (9 Months) | 2024 (9 Months) |
|---|---|---|
| Total Revenues | $4,328 million | $4,584 million |
| Gross Profit | $587 million | $678 million |
| Operating Income (Loss) | $(72) million | $38 million |
| Net Loss (GAAP) | $(145) million | $(2) million |
| Net Loss Attributable to Huntsman Corp | $(188) million | $(48) million |
| Adjusted EBITDA | $240 million | $343 million |
| Free Cash Flow | $105 million | $(7) million |
| Cash and Cash Equivalents | $468 million | $340 million (Dec 31, 2024) |
| Total Debt | $2,008 million | $1,835 million (Dec 31, 2024) |
Material Changes vs. Prior Period
- Revenue Decline: Revenues decreased 6% year-over-year to $4.328 billion, primarily due to lower average selling prices across all segments and lower sales volumes in Performance Products.
- Restructuring Costs: Restructuring, impairment, and plant closing costs surged to $137 million (vs. $20 million in 2024). This includes approximately $81 million in asset impairments related to the closure of the Moers, Germany maleic anhydride facility.
- One-Time Items:
- Gain on Acquisition: A $5 million gain was recognized in 2025 related to the SLIC joint venture separation (compared to a $51 million gain in 2024).
- Prepaid Asset Write-off: A $71 million write-off occurred in 2024 related to SLIC operating agreements; no such charge occurred in 2025.
- Litigation Income: The company recognized $33 million of income in 2025 related to the Praxair/Linde litigation settlement.
- Segment Performance: Adjusted EBITDA declined across all segments: Polyurethanes (-38%), Performance Products (-30%), and Advanced Materials (-12%).
Guidance, Outlook, and Risks
- Dividend Reduction: On November 3, 2025, the Board declared a cash dividend of $0.0875 per share, representing a 65% decrease from the previous $0.25 per share dividend.
- Capital Expenditures: The company expects to spend between $170 million and $180 million on capital expenditures for the full year 2025.
- Restructuring Outlook: Management expects to record approximately $2 million in further restructuring expenses through Q1 2026 related to the Moers facility closure. Additional expenses of $16 million are expected through 2027 for the Polyurethanes segment optimization.
- Liquidity: As of September 30, 2025, the company had $1.372 billion in combined cash and unused borrowing capacity. The company amended its 2022 Revolving Credit Facility to provide covenant relief through December 31, 2026, which limits restricted payments (including share repurchases) during this period.
- Risks: Key risks include continued soft market conditions, supply and demand dynamics affecting MDI prices, and the execution of restructuring programs.
Investor Verification Checklist
- Dividend Sustainability: Verify the rationale and long-term implications of the 65% dividend cut.
- Restructuring Execution: Monitor the timeline and cost realization of the Moers facility closure and other optimization programs.
- Debt Covenants: Review the specific terms of the "Covenant Relief Period" in the 2022 Revolving Credit Facility and its impact on capital allocation flexibility.
- Segment Margins: Assess whether the decline in average selling prices is temporary or indicative of a structural shift in the chemical market.
- Free Cash Flow: Confirm the sustainability of the improved free cash flow ($105 million) given the high level of restructuring charges.